![Kevin Connolly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kevin Connolly
Nessuna posizione attualmente
Profilo
Kevin Connolly worked as a Director-Anthrax Vaccines at PharmAthene, Inc. in 2011.
He completed his undergraduate degree at The Johns Hopkins University and his doctorate degree at Medical College of Virginia.
Precedenti posizioni note di Kevin Connolly
Società | Posizione | Fine |
---|---|---|
PharmAthene, Inc.
![]() PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Corporate Officer/Principal | - |
Formazione di Kevin Connolly
The Johns Hopkins University | Undergraduate Degree |
Medical College of Virginia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
PharmAthene, Inc.
![]() PharmAthene, Inc. BiotechnologyHealth Technology PharmAthene, Inc. engages in the development and commercialization of medical countermeasures against biological and chemical threats. Its development portfolio includes a next generation anthrax vaccine that is intended to provide protection while having dosage and storage requirements. The company was founded in March 2001 and is headquartered in Annapolis, MD. | Health Technology |
- Borsa valori
- Insiders
- Kevin Connolly